Biospecimen M&A: Discovery acquires Albert Li’s hepatocyte project; PhIII trial on Bayer’s Nubeqa reached primary endpoint

Discovery Life Sciences has acquired what claims to be the Maryland-based host of the world’s largest hepatocyte inventory, known as IVAL, to help researchers select more effective and safer drug candidates in the future.

The combined companies will now serve a wider range of drug research and development scientists, according...

Click to view original post